Good evening :)
Place Order
Add to Watchlist

Sanjivani Paranteral Ltd

SANJIVIN

Sanjivani Paranteral Ltd

SANJIVIN
Health CarePharmaceuticals
SmallcapWith a market cap of ₹352 cr, stock is ranked 2,086
High RiskStock is 3.20x as volatile as Nifty
324.154.99% (+15.40)
324.154.99% (+15.40)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹352 cr, stock is ranked 2,086
High RiskStock is 3.20x as volatile as Nifty

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹352 cr, stock is ranked 2,086
High RiskStock is 3.20x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
51.1112.64
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.906.610.52%

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Sanjivani Paranteral is engaged in the business of pharmaceutical products.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Higher than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 17.95%, vs industry avg of 9.03%

Increasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 0.01% to 0.02%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue116.2135.5218.4526.0516.6125.3630.8542.0259.4763.18
Raw Materialssubtract110.8028.6724.9414.609.9314.1412.6619.8434.3753.09
Power & Fuel Costsubtract1.050.961.080.730.580.780.981.101.14
Employee Costsubtract2.602.772.962.372.252.132.732.913.74
Selling & Administrative Expensessubtract4.085.093.112.762.602.917.225.329.45
Operating & Other expensessubtract2.4818.4538.096.391.333.011.306.662.01
Depreciation/Amortizationsubtract1.361.201.191.171.070.860.880.890.930.76
Interest & Other Itemssubtract8.814.790.450.330.660.130.210.360.250.37
Taxes & Other Itemssubtract-0.33-0.19-0.32-0.23-0.10-0.010.030.431.412.06
EPS-24.82-44.45-89.94-3.51-2.901.965.234.515.695.91
DPS0.000.000.000.000.000.000.000.000.000.00
Payout ratio0.000.000.000.000.000.000.000.000.000.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Sanjivani Paranteral Ltd57.1612.64
Sun Pharmaceutical Industries Ltd45.106.440.75%
Cipla Ltd29.414.520.87%
Torrent Pharmaceuticals Ltd68.5016.550.84%

Price Comparison

Compare SANJIVIN with any stock or ETF
Compare SANJIVIN with any stock or ETF
SANJIVIN
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Increased Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has increased by 1.16%

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding27.67%0.00%6.25%0.00%66.08%

Feb 2024

Mar 2024

Jun 2024

Sep 2024

Shareholding History

SepDec '23FebMarJunSep0.00%0.00%0.00%0.00%0.00%0.00%

Insider Trades & Bulk Deals

Loading...

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

SANJIVIN has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

Dividends

Hmm, looks like data is unavailable here. Please come back after some time
News & Opinions
Earnings
Sanjivani Paranteral standalone net profit rises 34.50% in the September 2024 quarter

Net profit of Sanjivani Paranteral rose 34.50% to Rs 2.30 crore in the quarter ended September 2024 as against Rs 1.71 crore during the previous quarter ended September 2023. Sales rose 29.50% to Rs 18.13 crore in the quarter ended September 2024 as against Rs 14.00 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales18.1314.00 30 OPM %15.7715.14 - PBDT3.072.22 38 PBT2.921.99 47 NP2.301.71 35 Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Sanjivani Paranteral announces board meeting date

Sanjivani Paranteral will hold a meeting of the Board of Directors of the Company on 28 October 2024.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Sanjivani Paranteral announces board meeting date

Sanjivani Paranteral will hold a meeting of the Board of Directors of the Company on 9 September 2024.Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Sanjivani Paranteral AGM scheduled

Sanjivani Paranteral announced that the 30th Annual General Meeting (AGM) of the company will be held on 24 September 2024.Powered by Capital Market - Live

3 months agoCapital Market - Live

Sanjivani Paranteral standalone net profit rises 10.32% in the June 2024 quarter

4 months agoBusiness Standard
Earnings
Sanjivani Paranteral standalone net profit rises 10.32% in the June 2024 quarter

Net profit of Sanjivani Paranteral rose 10.32% to Rs 1.71 crore in the quarter ended June 2024 as against Rs 1.55 crore during the previous quarter ended June 2023. Sales rose 30.68% to Rs 16.44 crore in the quarter ended June 2024 as against Rs 12.58 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales16.4412.58 31 OPM %14.1715.98 - PBDT2.402.03 18 PBT2.271.80 26 NP1.711.55 10 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Sanjivani Paranteral to announce Quarterly Result

Sanjivani Paranteral will hold a meeting of the Board of Directors of the Company on 6 August 2024.Powered by Capital Market - Live

4 months agoCapital Market - Live

Sanjivani Paranteral standalone net profit rises 1.44% in the March 2022 quarter

2 years agoBusiness Standard

Sanjivani Paranteral standalone net profit rises 344.00% in the September 2021 quarter

3 years agoBusiness Standard

Sanjivani Paranteral reports standalone net profit of Rs 0.63 crore in the June 2021 quarter

3 years agoBusiness Standard